Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001037840 | SCV001201272 | benign | Adams-Oliver syndrome 5 | 2023-05-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001759730 | SCV001986401 | uncertain significance | not provided | 2024-08-28 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis indicates that this missense variant does not alter protein structure/function |
Genome- |
RCV001037840 | SCV002553999 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271168 | SCV002554000 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354983 | SCV002648281 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-05-05 | criteria provided, single submitter | clinical testing | The p.T194I variant (also known as c.581C>T), located in coding exon 4 of the NOTCH1 gene, results from a C to T substitution at nucleotide position 581. The threonine at codon 194 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
CHEO Genetics Diagnostic Laboratory, |
RCV002354983 | SCV004239535 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-11-08 | criteria provided, single submitter | clinical testing |